Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation.

Gertz ER, Silverman NE, Wise KS, Hanson KB, Alekel DL, Stewart JW, Perry CD, Bhupathiraju SN, Kohut ML, Van Loan MD.

J Clin Densitom. 2010 Jul-Sep;13(3):277-82. doi: 10.1016/j.jocd.2010.04.003.

2.

Soy protein consumption and bone mass in early postmenopausal Chinese women.

Ho SC, Woo J, Lam S, Chen Y, Sham A, Lau J.

Osteoporos Int. 2003 Oct;14(10):835-42. Epub 2003 Aug 14. Review.

PMID:
12920508
3.

One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women.

Arjmandi BH, Lucas EA, Khalil DA, Devareddy L, Smith BJ, McDonald J, Arquitt AB, Payton ME, Mason C.

Nutr J. 2005 Feb 23;4:8.

4.

Fat or lean tissue mass: which one is the major determinant of bone mineral mass in healthy postmenopausal women?

Chen Z, Lohman TG, Stini WA, Ritenbaugh C, Aickin M.

J Bone Miner Res. 1997 Jan;12(1):144-51.

5.

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.

J Bone Miner Res. 1996 Mar;11(3):337-49.

PMID:
8852944
6.

Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.

Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T.

Am J Clin Nutr. 2000 Sep;72(3):844-52.

7.
8.

Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.

Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, Holm-Jensen T.

Eur J Nutr. 2004 Aug;43(4):246-57. Epub 2004 Apr 14.

PMID:
15309425
9.

Apparent bone mineral density estimated from DXA in healthy men and women.

Cvijetić S, Korsić M.

Osteoporos Int. 2004 Apr;15(4):295-300. Epub 2003 Nov 20.

PMID:
14628108
10.

The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.

Alekel DL, Van Loan MD, Koehler KJ, Hanson LN, Stewart JW, Hanson KB, Kurzer MS, Peterson CT.

Am J Clin Nutr. 2010 Jan;91(1):218-30. doi: 10.3945/ajcn.2009.28306. Epub 2009 Nov 11.

11.

Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.

Ding C, Parameswaran V, Udayan R, Burgess J, Jones G.

J Clin Endocrinol Metab. 2008 May;93(5):1952-8. doi: 10.1210/jc.2007-2325. Epub 2008 Feb 19.

PMID:
18285417
12.

Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women.

Salamone LM, Whiteside T, Friberg D, Epstein RS, Kuller LH, Cauley JA.

Calcif Tissue Int. 1998 Dec;63(6):466-70.

PMID:
9817939
13.

[Relationship between estrogen receptor gene Px haplotype and the effect of calcium and soy isoflavone supplementation on bone mineral density of Chinese postmenopausal women].

Dong J, Huang ZW, Piao JH, Li F, Zeng J, Gong J, Yang XG.

Zhonghua Yu Fang Yi Xue Za Zhi. 2008 May;42(5):329-34. Chinese.

PMID:
18844082
14.

The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study.

Dundar U, Kavuncu V, Ciftci IH, Evcik D, Solak O, Cakir T.

J Bone Miner Metab. 2009;27(4):464-70. doi: 10.1007/s00774-009-0055-9. Epub 2009 Mar 20.

PMID:
19301089
15.

Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study.

Garnero P, Borel O, Sornay-Rendu E, Duboeuf F, Jeffery R, Woo P, Delmas PD.

Bone. 2002 Jul;31(1):43-50.

PMID:
12110411
16.

Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.

Uretmen S, Gol M, Cimrin D, Irmak E.

Eur J Obstet Gynecol Reprod Biol. 2005 Nov 1;123(1):67-71. Epub 2005 Jul 26.

PMID:
16051419
17.

Differences in mineral homeostasis, volumetric bone mass and femoral neck axis length in black and white South African women.

Daniels ED, Pettifor JM, Schnitzler CM, Moodley GP, Zachen D.

Osteoporos Int. 1997;7(2):105-12.

PMID:
9166389
18.

Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.

Sienkiewicz E, Magkos F, Aronis KN, Brinkoetter M, Chamberland JP, Chou S, Arampatzi KM, Gao C, Koniaris A, Mantzoros CS.

Metabolism. 2011 Sep;60(9):1211-21. doi: 10.1016/j.metabol.2011.05.016. Epub 2011 Jul 7.

PMID:
21741057
19.

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

Clin Ther. 2007 Sep;29(9):1937-49.

PMID:
18035193
20.

Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.

Nabipour I, Larijani B, Vahdat K, Assadi M, Jafari SM, Ahmadi E, Movahed A, Moradhaseli F, Sanjdideh Z, Obeidi N, Amiri Z.

Menopause. 2009 Sep-Oct;16(5):950-5. doi: 10.1097/gme.0b013e3181a181b8.

PMID:
19387415
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk